Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes (2009)
- Authors:
- USP affiliated authors: BERNIK, MARCIA MARTINS SILVEIRA - HU ; DOREA, EGIDIO LIMA - HU ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: HU; FCF
- Subjects: LEPTINA; OBESIDADE; DIABETES MELLITUS
- Language: Inglês
- Imprenta:
- Source:
- Título: Atherosclerosis Supplements
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 10, n. 3, p. 15 res. D010, 2009
- Conference titles: Brazilian Congress of Atherosclerosis
-
ABNT
OLIVEIRA, R. et al. Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. Amsterdam: Hospital Universitário, Universidade de São Paulo. . Acesso em: 29 dez. 2025. , 2009 -
APA
Oliveira, R., Sampaio, M. F., Armaganijan, D., Bernick, M. M. S., Dórea, E. L., Hirata, M. H., & Hirata, R. D. C. (2009). Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. Amsterdam: Hospital Universitário, Universidade de São Paulo. -
NLM
Oliveira R, Sampaio MF, Armaganijan D, Bernick MMS, Dórea EL, Hirata MH, Hirata RDC. Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. 2009 ; 10( 3): 15 res. D010.[citado 2025 dez. 29 ] -
Vancouver
Oliveira R, Sampaio MF, Armaganijan D, Bernick MMS, Dórea EL, Hirata MH, Hirata RDC. Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. 2009 ; 10( 3): 15 res. D010.[citado 2025 dez. 29 ] - CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin down-regulates ABCA1 gene expression in peripheral blood mononuclear cells of Brazilian hyper-cholesterolemic patients
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
- Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
- Estudo da expressão gênica e polimorfismos da CYP3A5 em indivíduos hipercolesterolêmicos tratados com atorvastatina
- Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
- Resposta hipolipemiante à atorvastatina é modificada pelo polimorfismo do gene da CYP3A5
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
